Ionpath delivers high definition spatial proteomics, revolutionizing tissue imaging and analysis to accelerate discovery and improve human health. Ionpath’s MIBI™ (multiplexed ion beam imaging) Platform breaks through the limitations of traditional IHC, enabling deep understanding of the tissue microenvironment with highly multiplexed quantitative single-cell analysis. With MIBI technology and the expertise of world class pathology and data science teams, Ionpath provides actionable insights to translational and clinical researchers at leading pharma, biotech, and research organizations in immuno-oncology, immunology, neuroscience and infectious disease research.
Location: United States, California, Menlo Park
Member count: 11-50
Phone: +1 833-466-7284
Total raised: $18M
Founded date: 2014
Investors 3
| Date | Name | Website |
| 10.02.2021 | Genoa Vent... | genoavc.co... |
| - | ND CAPITAL | nd.capital |
| - | Vertical V... | vvp.vc |
Funding Rounds 1
| Date | Series | Amount | Investors | Deal News |
| 24.09.2020 | Series B | $18M | - | finsmes.co... |
Mentions in press and media 4
| Date | Title | Description | Category | Author | Source |
| 26.08.2021 | Ionpath Ex... | MENLO PARK, Calif., Aug. 26,... | - | - | prnewswire... |
| 28.09.2020 | IONpath Ra... | IONpath, Inc., a Menlo Park, C... | USA | - | finsmes.co... |
| 24.09.2020 | IONpath Cl... | Proceeds will be used for the ... | - | - | vvp.vc/ion... |
| 24.09.2020 | IONpath Cl... | MENLO PARK, Calif., Sept. 24... | - | - | prnewswire... |